✦ LIBER ✦

The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease

✍ Scribed by S. Kunzendorf; G. Jantschek; K. Straubinger; I. Heberlein; N. Homann; D. Ludwig; D. Benninghoven

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 347 KB
Volume: 13
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20050

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Psychosocial factors play an important role in the course of inflammatory bowel disease (ibd). however, a simple, valid psychosocial screening instrument that is suitable for short patient-physician contacts does not exist. therefore, the luebeck semistructured interview for psychosocial screening was developed as a rating tool for psychosocial stress in ibd patients (lips-ibd).

Method:

The entire interview requires approximately 10 minutes. interrater reliability was tested. depression, anxiety, social support, impact of the disease, global level of psychosocial stress, and demand for psychosocial support were rated in 92 patients with ibd on 5 point likert scales. patients from the in- and out-patient clinic for gastroenterology were included. in addition, patients filled out self-report questionnaires regarding depression, anxiety, social support, and impact of the disease. indices of disease activity (colitis activity index, crohn's disease activity index) were recorded.

Results:

Both patients and physicians found the interview feasible. reliability was good, with interrater reliability ranging from .76 to .94. convergence with self-report instruments was also high (r = .5-.6). ratings of depression and impact of the disease were correlated with indices of disease activity.

Discussion:

Lips helps to identify patients with high levels of psychosocial stress and provide them with more detailed psychologic assessments. it was found to be a suitable instrument for daily clinical routine. it is potentially a valuable screening tool to obtain reliable, valid, and useful information in daily practice in ibd treatment settings.

📜 SIMILAR VOLUMES

Disability in inflammatory bowel disease

Disability in inflammatory bowel diseases: Developing ICF core sets for patients with inflammatory bowel diseases based on the international classification of functioning, disability, and health

✍ Laurent Peyrin-Biroulet; Alarcos Cieza; William J. Sandborn; Nenad Kostanjsek; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

The inflammatory bowel diseases (IBDs) are associated with a reduced quality of life. The impact of IBD on disability remains largely unknown. With the International Classification of Functioning, Disability, and Health (ICF) of the World Health Organization (WHO), we can now rely on a globally agre

Anxiety and depression in patients with

Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population

✍ Winfried Häuser; Karl-Heinz Janke; Bodo Klump; Andreas Hinz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

Background: Studies on anxiety and depression in inflammatory bowel disease (IBD) yielded inconsistent results. We compared anxiety and depression of patients with Crohn's disease (CD) and ulcerative colitis (UC) controlled for sociodemographic and medical variables with age-and sex-matched controls

QuantiFERON TB gold testing for tubercul

QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States

✍ Bashar J. Qumseya; Ashwin N. Ananthakrishnan; Sue Skaros; Michael Bonner; Mazen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Background: Reactivation of latent Mycobacterium tuberculosis (TB) is a rare, yet devastating infectious complication associated with anti-tumor necrosis factor alpha (TNF-a) therapy. We evaluated the performance of the QuantiFERON TB Gold test (QFT-G) for TB screening in a cohort of inflammatory bo

The long term effects of proctectomy on

The long term effects of proctectomy on bladder function in patients with inflammatory bowel disease

✍ David E. Neal; Andrew J. Parker; Norman S. Williams; David Johnston 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 2 views

## Abstract The effect on bladder function of protectomy for colitis or Crohn's disease was studied by means of a questionnaire and by pressure/flow cystometry. Thirty-seven patients who had undergone protectomy for inflammatory bowel disease were compared with 34 control patients who had undergone

Misclassification of dysplasia in patien

Misclassification of dysplasia in patients with inflammatory bowel disease: Consequences for progression rates to advanced neoplasia

✍ Fiona D.M. van Schaik; Fiebo J.W. ten Kate; G. Johan A. Offerhaus; Marguerite E. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 1 views

## Background: The natural behavior of flat low-grade (LGD) and indefinite dysplasia (IND) in patients with inflammatory bowel disease (IBD) remains uncertain and seems to be dependent on the interpretation of the pathologist. We studied the progression rate of flat LGD and IND to advanced neoplas

What is the best test for the patient wi

What is the best test for the patient with inflammatory bowel disease: Colonoscopy or the barium enema?

✍ Dr. Jerome D. Waye 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

The answer to the question of which is the best test lies in the timing of the particular examination relative to the course of the disease. For the initial diagnosis and institution of therapy, the flexible sigmoidoscopic examination, which visualizes the mucosa in the distal colon, coupled with a